131 related articles for article (PubMed ID: 17023755)
1. [A case of ulcerative colitis with hematuria and renal dysfunction after leukocytapheresis].
Makino K; Masutani M; Sato S; Hamamoto H
Nihon Shokakibyo Gakkai Zasshi; 2006 Oct; 103(10):1134-8. PubMed ID: 17023755
[TBL] [Abstract][Full Text] [Related]
2. Influence of leukocytapheresis therapy for ulcerative colitis on anemia and hemodynamics.
Miyamoto H; Okahisa T; Iwaki H; Murata M; Ito S; Nitta Y; Akutagawa M; Kinouchi Y; Ohnishi Y; Oto J; Nishimura M
Ther Apher Dial; 2007 Feb; 11(1):16-21. PubMed ID: 17309570
[TBL] [Abstract][Full Text] [Related]
3. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.
Nagayama K; Takedatsu H; Mitsuyama K; Yamasaki H; Kuwaki K; Yoshioka S; Kobayashi T; Yamauchi R; Kakuma T; Sata M
Ther Apher Dial; 2014 Jun; 18(3):244-51. PubMed ID: 24965290
[TBL] [Abstract][Full Text] [Related]
4. A case report: first case of filtration leukocytapheresis for a patient of aortitis syndrome associated with ulcerative colitis.
Fukunaga K; Sawada K; Fukuda Y; Matoba Y; Onishi K; Fukui S; Yamamura M; Satomi M; Shimoyama T
Ther Apher; 2002 Feb; 6(1):93-8. PubMed ID: 11886584
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis.
Kobayashi T; Matsuoka K; Yokoyama Y; Nakamura T; Ino T; Numata T; Shibata H; Aoki H; Matsuno Y; Hibi T
J Gastroenterol; 2018 Mar; 53(3):387-396. PubMed ID: 28597225
[TBL] [Abstract][Full Text] [Related]
6. LEUKOCYTAPHERESIS IN THE MANAGEMENT OF SEVERE STEROID-DEPENDENT ULCERATIVE COLITIS.
Krznarić Ž; Markoš P; Golubić Ćepulić B; Čuković-Čavka S; Domislović V; Bojanić I; Barišić A; Kekez D
Acta Clin Croat; 2019 Sep; 58(3):529-534. PubMed ID: 31969767
[TBL] [Abstract][Full Text] [Related]
7. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.
Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Kikuyama M; Tanaka T; Kondo K; Tanaka K; Takai K
World J Gastroenterol; 2005 May; 11(20):3085-90. PubMed ID: 15918195
[TBL] [Abstract][Full Text] [Related]
8. [A case of tacrolimus plus intensive LCAP therapy combination for refractory ulcerative colitis].
Matsumoto A; Yajima H; Murata T; Gotou K; Okamoto K; Nishiyama H
Nihon Shokakibyo Gakkai Zasshi; 2013 Apr; 110(4):639-47. PubMed ID: 23558127
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis.
Umehara Y; Kudo M; Kawasaki M
World J Gastroenterol; 2008 Sep; 14(34):5316-21. PubMed ID: 18785285
[TBL] [Abstract][Full Text] [Related]
10. [Remission by leukocytapheresis for a patient with ulcerative colitis found refractory by conventional drug therapies].
Sawada K; Ohnishi K; Kosaka T; Egashira A; Kinoshita T; Amano K; Yamamura M; Satomi M; Shimoyama T
Nihon Rinsho Meneki Gakkai Kaishi; 1997 Apr; 20(2):126-33. PubMed ID: 9178970
[TBL] [Abstract][Full Text] [Related]
11. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M
J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
[TBL] [Abstract][Full Text] [Related]
12. [A case of sacroiliitis complicated with ulcerative colitis which was treated with leukocytapheresis].
Norimura D; Mizuta Y; Isomoto H; Yamaguchi N; Ohnita K; Shikuwa S; Takeshima F; Nakao K
Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):605-11. PubMed ID: 20379094
[TBL] [Abstract][Full Text] [Related]
13. Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon.
Sawada K; Egashira A; Ohnishi K; Fukunaga K; Kusaka T; Shimoyama T
Dig Dis Sci; 2005 Apr; 50(4):767-73. PubMed ID: 15844716
[TBL] [Abstract][Full Text] [Related]
14. Leukocytapheresis therapy for severe ulcerative colitis.
Sasaki M; Tsujikawa T; Fujiyama Y; Bamba T
Ther Apher; 1998 May; 2(2):101-4. PubMed ID: 10225708
[TBL] [Abstract][Full Text] [Related]
15. Relationship between ulcerative colitis patients treated with leukocytapheresis and ulcerative colitis-associated colorectal cancer.
Kinugasa T; Akagi Y; Murotani K; Romeo K; Yoshida T; Ryu Y; Shiratuchi I; Shirouzu K
Anticancer Res; 2011 Jul; 31(7):2547-52. PubMed ID: 21873173
[TBL] [Abstract][Full Text] [Related]
16. Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.
Emmrich J; Petermann S; Nowak D; Beutner I; Brock P; Klingel R; Mausfeld-Lafdhiya P; Liebe S; Ramlow W
Dig Dis Sci; 2007 Sep; 52(9):2044-53. PubMed ID: 17410456
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients.
Takemoto K; Kato J; Kuriyama M; Nawa T; Kurome M; Okada H; Sakaguchi K; Shiratori Y
Dig Liver Dis; 2007 May; 39(5):422-9. PubMed ID: 17379587
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of response to leukocytapheresis therapy for ulcerative colitis.
Yajima T; Takaishi H; Kanai T; Iwao Y; Watanabe M; Ishii H; Hibi T
Ther Apher; 1998 May; 2(2):115-9. PubMed ID: 10225711
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of leukocytapheresis effect in the treatment of ulcerative colitis].
Sawada K; Ohnishi K; Fukunaga K; Chikano S; Egashira A; Satomi M; Shimoyama T
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):469-74. PubMed ID: 10726487
[TBL] [Abstract][Full Text] [Related]
20. [Leukocytapheresis for ulcerative colitis].
Fukunaga K; Sawada K; Chikano S; Ohnishi K; Egashira A; Tanaka J; Nagase K; Satomi M; Shimoyama T
Nihon Rinsho; 1999 Nov; 57(11):2496-502. PubMed ID: 10572419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
